Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial Comparing Two Neoadjuvant Treatments in Patients With Ultra-low Rectal Cancer: High-dose Radiotherapy Versus Radio-chemotherapy

NCT00979680 is registered in ClinicalTrials.gov with Institut du Cancer de Montpellier - Val d'Aurelle as lead sponsor.

NCT NCT00979680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00979680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial Comparing Two Neoadjuvant Treatments in Patients With Ultra-low Rectal Cancer: High-dose Radiotherapy Versus Radio-chemotherapy
Lead sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2001
Completion date
September 30, 2007
Enrollment
207 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer